PRETE, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.057
AS - Asia 1.244
EU - Europa 782
SA - Sud America 270
AF - Africa 90
OC - Oceania 1
Totale 4.444
Nazione #
US - Stati Uniti d'America 2.009
SG - Singapore 483
CN - Cina 338
BR - Brasile 233
IT - Italia 223
HK - Hong Kong 217
DE - Germania 144
SE - Svezia 75
AT - Austria 65
VN - Vietnam 51
FR - Francia 47
GB - Regno Unito 45
FI - Finlandia 44
BG - Bulgaria 31
CI - Costa d'Avorio 30
CA - Canada 24
IN - India 22
KR - Corea 22
SN - Senegal 21
JP - Giappone 20
RU - Federazione Russa 20
TR - Turchia 19
PL - Polonia 18
AR - Argentina 16
MA - Marocco 16
MX - Messico 16
EE - Estonia 15
BD - Bangladesh 14
ZA - Sudafrica 13
NL - Olanda 11
ES - Italia 9
UZ - Uzbekistan 8
IQ - Iraq 7
UA - Ucraina 7
EC - Ecuador 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
MG - Madagascar 5
PK - Pakistan 5
AZ - Azerbaigian 4
CL - Cile 4
GR - Grecia 4
IE - Irlanda 4
JO - Giordania 4
LT - Lituania 4
VE - Venezuela 4
BE - Belgio 3
CO - Colombia 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
GT - Guatemala 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
PY - Paraguay 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 4.444
Città #
Dallas 556
Ashburn 298
Singapore 284
Hong Kong 214
Santa Clara 157
Chandler 131
Shanghai 92
Munich 88
New York 82
Los Angeles 72
Vienna 61
Beijing 60
Fairfield 49
Pisa 48
Boardman 43
Hefei 34
Sofia 31
Abidjan 30
Milan 29
Houston 28
Woodbridge 27
Redondo Beach 26
São Paulo 25
Florence 24
Frankfurt am Main 24
Helsinki 24
Seoul 22
Cambridge 21
Dakar 21
Princeton 21
Rome 21
Lawrence 19
Wilmington 19
Seattle 18
Tokyo 17
Turku 17
Ho Chi Minh City 16
London 16
Medford 15
Warsaw 14
Buffalo 13
Denver 12
Phoenix 12
Poplar 12
Casablanca 11
Hanoi 11
Ogden 11
Atlanta 10
Brooklyn 10
Johannesburg 10
Cascina 9
Düsseldorf 9
Lucca 9
Nuremberg 9
Orem 9
San Diego 9
Serra 9
Belo Horizonte 8
Fuzhou 8
Istanbul 8
Montreal 8
Boston 7
Lauterbourg 7
Stockholm 7
Tashkent 7
Washington 7
Changchun 6
Chicago 6
Quanzhou 6
Antananarivo 5
Bremen 5
Chiesina Uzzanese 5
Mexico City 5
Mumbai 5
Presidente Prudente 5
Redmond 5
Amman 4
Ankara 4
Ann Arbor 4
Baghdad 4
Baku 4
Dublin 4
Livorno 4
Paris 4
Porto Alegre 4
Quito 4
Toronto 4
Vancouver 4
Vicopisano 4
Wroclaw 4
Xiamen 4
Zhengzhou 4
Amsterdam 3
Bagé 3
Bologna 3
Brasília 3
Brno 3
Brussels 3
Caracas 3
Chennai 3
Totale 3.177
Nome #
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 183
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 158
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 153
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 145
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma 141
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 140
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 132
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 132
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 130
Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase? 119
Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature 114
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 111
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 111
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 111
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance 110
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 110
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 107
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 103
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer 103
Firm mass in thyroid of an elderly patient: Not always cancer 101
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 100
Use of non-nutritive-sweetened soft drink and risk of gestational diabetes 99
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 96
Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report 96
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 94
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 93
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance 92
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments 90
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 89
Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Journal of Endocrinological Investigation, (2021), 44, 10, (2139-2151), 10.1007/s40618-020-01491-3) 89
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 88
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer 88
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments 83
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination 75
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review 73
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 72
The challenge of the differential diagnosis between brown tumors and metastases in parathyroid carcinoma: a case report 70
Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules 67
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine 67
MULTIFOCALITY AND BILATERALITY IN MEDULLARY THYROID CANCER: BASIS FOR A PROOF-OF-CONCEPT SAFETY OF LOBECTOMY 66
Inflammation-based scores in patients with pheochromocytoma 64
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib 63
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients 60
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 49
State of the Art in 3D Culture Models Applied to Thyroid Cancer 43
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer 41
null 19
Totale 4.540
Categoria #
all - tutte 14.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 19 14 14 13 4 18 17
2021/2022174 7 0 4 0 26 22 13 9 11 12 16 54
2022/2023452 40 49 41 38 51 51 2 41 96 3 32 8
2023/2024343 17 29 54 26 42 66 21 3 5 9 27 44
2024/20251.562 21 58 28 85 160 114 167 86 156 172 199 316
2025/20261.828 202 474 394 305 303 150 0 0 0 0 0 0
Totale 4.540